CURRENT TREATMENT OPTIONS FOR METASTATIC BREAST CANCER
Breast cancer (BC) is the most common type of cancer worldwide. The main cause of death in these patients is the progression of the process associated with the development of distant metastases. Five-year survival of these patients does not exceed 40 %. The most important task in the treatment of generalized breast cancer is to prolong life without losing its quality. Currently, approaches to the treatment of patients with metastatic breast cancer has undergone a significant correction. The treatment of this pathology was comprehensive, including all the features of modern oncological science. Advances in molecular biology have provided a further point of application in the form of targeted treatment. The application of new schemes and modes of chemotherapy, improved diagnostic methods, the possibility of stereotactic radiation therapy, minimally invasive surgical interventions – all this allows long enough to keep control of the tumor process, increases life expectancy of patients with minimal adverse impact of treatment on quality of life. In addition, the therapy of such patients is highly individualized. Thus, despite the fact that metastatic breast cancer remains incurable to date, this condition should be considered as a chronic process that requires constant monitoring and highly individualized approach to treatment.